LivaNova

About LivaNova

LivaNova PLC is a global medical technology innovator with nearly five decades of experience dedicated to enhancing patient lives worldwide. Our advanced technologies and breakthrough treatments deliver significant solutions for patients, healthcare professionals, and systems. We focus on providing clinical and economic value to our customers as a market-leading medical technology and services company with a diverse product range and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol “LIVN.” With approximately 2,900 employees, our headquarters are in London, UK, and we operate in over 100 countries. A global leader in cardiopulmonary and neuromodulation, we are committed to creating impactful products and therapies that transform lives every day.